Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
6-fluoro-2-[2-hydroxy-3-(2-methyl-cyclohexyloxy)-phenyl]-1H-indole-5-carboxamidine
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
6-fluoro-2-[2-hydroxy-3-(2-methyl-cyclohexyloxy)-phenyl]-1H-indole-5-carboxamidine is a synthetic small molecule belonging to the class of organic compounds known as 2‑phenylindoles[1][2][3]. It features an indole core substituted with a phenolic group and a carboxamidine moiety. The compound has been studied experimentally and is not approved for clinical use. Its mechanism of action involves inhibition of serine proteases, including coagulation factor X (FA10), plasminogen (PLMN), prothrombin (THRB), tissue-type plasminogen activator (TPA), trypsin, and urokinase-type plasminogen activator (UROK)[1]. These targets suggest potential anticoagulant or antifibrinolytic activity, but there are no indications that it has advanced beyond experimental research.
- Other names
- 6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE6-fluoro-2-(2-hydroxy-3-{[(1S,2S)-2-methylcyclohexyl]oxy}phenyl)-1H-indole-5-carboximidamide
02
Targets
F10 (Factor Xa)PLG (Plasminogen)PLAT (Tissue-type plasminogen activator)PRSS1 (Trypsin family)F2 (Thrombin)PLAU (uPA)
Beyond the preview
Go deeper on 6-fluoro-2-[2-hydroxy-3-(2-methyl-cyclohexyloxy)-phenyl]-1H-indole-5-carboxamidine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 6-fluoro-2-[2-hydroxy-3-(2-methyl-cyclohexyloxy)-phenyl]-1H-indole-5-carboxamidine.